Patents Assigned to VSL Pharma Limited
  • Patent number: 6562336
    Abstract: This invention provides materials and procedures for the delivery of selected strains of bacteria and/or oxalate-degrading enzymes to the intestinal tracts of persons who are at increased risk for oxalate related disease because they have lost, or have inadequate concentrations of these bacteria. The administration of these bacteria and/or the relevant enzyme removes oxalate from the intestinal tract and thus reduces the amount of oxalate available for absorption and reduces the risk for oxalate related disease.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: May 13, 2003
    Assignee: VSL Pharma Limited
    Inventor: Claudio De Simone